Results 141 to 150 of about 1,282 (161)
Some of the next articles are maybe not open access.
PTLD in liver transplant recipients
Transplantation Proceedings, 2001M, Rizell, M, Olausson, S, Friman
openaire +2 more sources
Organ Specific Issues of PTLD — Kidney
2010Incidence of Posttransplant lymphoproliferative disorders (PTLD) in kidney transplant recipients is relatively low: 0.4% at 1 year, 1.2% at 5 years, and 1.6% after 10 years. Risk factors of PTLD in kidney transplant recipients are principally EBV seronegativity and high level of immunosuppression.
openaire +1 more source
PTLD – rationale Prävention und Therapie
Nieren- und Hochdruckkrankheiten, 2018M. Choi, R. Trappe
openaire +1 more source
Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.
Seminars in thoracic and cardiovascular surgery, 1996Posttransplant lymphoproliferative disorders (PTLDs) are a family of lymphoid hyperplasias and neoplasias that occur in the context of organ transplantation and immunosuppression. A strong association exists with Epstein-Barr virus (EBV) infection of the B lymphocyte.
openaire +1 more source
Post-transplant Lymphoproliferative Disorder (PTLD)
Clinical Oncology, 2007D.W. Petrik, R. Lai, R.G. Pearcey
openaire +1 more source
Post-Transplant Lymphoproliferative Disorder (PTLD)
American Journal of Gastroenterology, 2005David Koch +5 more
openaire +1 more source
Hodgkin's‐like PTLD versus true Hodgkin's disease
Pediatric Transplantation, 2004Vikas R, Dharnidharka +1 more
openaire +2 more sources